Note: Ingredients listed on restricted chemical lists
EC/CAS
215-137-3/1305-62-0
Name of the chemical
Calcium dihydroxide
Concentration
2.5-<10
EC/CAS
232-674-9/9004-34-6
Name of the chemical
cellulose
Concentration
0.1-<1.0
General Information
Version
9
Revision date
2023-07-06
Product name
Perlifoc HP
Product name
Perlifoc HP
Identification on the label/Trade name
11-104
supplier name
CHEMTREC +1 703 5273887 (Outside US)
Manufacturer Name
Perlita y Vermiculita, S.L.U
Emergency telephone
+34 91.562.04.20
Icons in SDS
Company Information
company name
Perlita y Vermiculita, S.L.U
e-mail address of the competent person responsible for the Safety Data Sheet
info@perlitayvermiculita.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H318
Hazard statements
Code
Statements
H318
Causes serious eye damage
Section 2
SECTION 2: Hazards identification
1272/2008 Classification of the substance or mixture
2.2 Label elements
Symbol(s) of Product
Signal word
Danger Named Chemicals on Label Calcium hydroxide
Hazard statements
Serious Eye Damage, category 1 H318 Causes serious eye damage.
Precautionary statements
P280 Wear protective gloves/protective clothing/eye protection/ face protection. P301+310 IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. P305+351+338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do so. Continue rinsing.
2.3 Other hazards
No Information
Results of PBT and vPvB assessment
The product does not meet the criteria for PBT/VPvB in accordance with Annex XIII. Endocrine disrupting properties - Toxicity Name According to EEC CAS-No. Based on the available data, the product does not contain substances identified as having endocrine disrupting properties according to Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 in concentration of 0,1% or higher. Endocrine disrupting properties - Ecotoxicity Name According to EEC CAS-No. Based on the available data, the product does not contain substances identified as having endocrine disrupting properties according to Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 in concentration of 0,1% or higher.
2.1 Classification of the substance or mixture
Classification according to Classification, Labeling & Packaging Regulation (EC) 1272/2008 HAZARD STATEMENTS Serious Eye Damage, category 1 H318
